Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms
Simon Mobach1,2,3, Nick D Bergkamp1, Ziliang Ma4,5
1Department of Chemistry and Pharmaceutical Sciences, Division of Medicinal Chemistry, Amsterdam Institute for Molecular and Life Sciences, Vrije Universiteit Amsterdam, Amsterdam 1081 HZ, The Netherlands.
Abstract:
The chemokine receptor CXCR4 is overexpressed in many cancers and contributes to pathogenesis, disease progression, and resistance to therapies. CXCR4 is known to form oligomers, but the potential functional relevance in malignancies remains elusive. Using a nanobody-based BRET method, we demonstrate that oligomerization of endogenous CXCR4 on lymphoid cancer cell lines correlates with enhanced expression levels. Specific disruption of CXCR4 oligomers reduced basal cell migration and prosurvival signaling via changes in the phosphoproteome, indicating the existence of constitutive CXCR4 oligomer-mediated signaling. Oligomer disruption also inhibited growth of primary CLL 3D spheroids and sensitized primary malignant cells to clinically used Bcl-2 inhibitor venetoclax. Given its limited efficacy in some patients and the ability to develop resistance, sensitizing malignant B cells to venetoclax is of clinical relevance. Taken together, we established a noncanonical and critical role for CXCR4 oligomers in lymphoid neoplasms and demonstrated that their selective targeting has clinical potential.
Insights
CXCR4 receptor oligomers play a critical role in lymphoid cancers. Disrupting these CXCR4 oligomers inhibits cancer cell growth and enhances sensitivity to venetoclax therapy.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Chemokine receptor CXCR4 is overexpressed in cancers, contributing to disease progression and therapy resistance.
- CXCR4 oligomerization's role in malignancies is not well understood.
- Targeting CXCR4 may offer therapeutic benefits in cancer treatment.
Purpose of the Study:
- To investigate the functional relevance of CXCR4 oligomerization in lymphoid cancers.
- To determine if disrupting CXCR4 oligomers impacts cancer cell signaling and drug sensitivity.
- To explore the therapeutic potential of targeting CXCR4 oligomers.
Main Methods:
- Utilized a nanobody-based BRET method to study endogenous CXCR4 oligomerization.
- Analyzed changes in cell migration, prosurvival signaling, and phosphoproteome upon oligomer disruption.
- Assessed the effect of oligomer disruption on chronic lymphocytic leukemia (CLL) spheroid growth and venetoclax sensitivity.
Main Results:
- CXCR4 oligomerization correlated with increased expression in lymphoid cancer cell lines.
- Disruption of CXCR4 oligomers reduced cell migration and prosurvival signaling.
- Oligomer disruption inhibited primary CLL spheroid growth and sensitized malignant cells to venetoclax.
Conclusions:
- CXCR4 oligomers play a noncanonical, critical role in lymphoid neoplasms.
- Selective targeting of CXCR4 oligomers demonstrates clinical potential for sensitizing malignant B cells to venetoclax.
- Disrupting CXCR4 oligomers represents a promising therapeutic strategy in lymphoid malignancies.
More Related Videos
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Inhibition of Cdk Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
